National Institute of Mental Health; Notice of Closed Meeting, 6617-6618 [2022-02373]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 3100, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Keith McKenney, Ph.D,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Suite 3100, Bethesda, MD 20817, 301–594–
4280, mckenneyk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: January 31, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–02331 Filed 2–3–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Centers for HIV Structural
Biology (U54 Clinical Trial Not Allowed).
Date: March 2–3, 2022.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: J. Bruce Sundstrom, Ph.D.,
Scientific Review Officer, Scientific Review
Program, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11A,
Rockville, MD 20892, 240–669–5045,
sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
18:50 Feb 03, 2022
Jkt 256001
Dated: January 31, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–02346 Filed 2–3–22; 8:45 am]
BILLING CODE 4140–01–P
6617
Cancer Control, National Institutes of Health,
HHS)
Dated: February 1, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–02367 Filed 2–3–22; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute; Notice of
Meeting
National Institutes of Health
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Frederick National
Laboratory Advisory Committee to the
National Cancer Institute.
The meeting will be held virtually
and is open to the public. Individuals
who plan to view the virtual meeting
and need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The meeting will be videocast
and can be accessed from the NIH
Videocasting and Podcasting website
(https://videocast.nih.gov).
National Institute on Aging; Amended
Notice of Meeting
Name of Committee: Frederick National
Laboratory Advisory Committee to the
National Cancer Institute.
Date: February 24, 2022.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: Ongoing and new activities at the
Frederick National Laboratory for Cancer
Research.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
Contact Person: Wlodek Lopaczynski,
M.D., Ph.D., Assistant Director, Office of the
Director, Division of Extramural Activities,
National Cancer Institute, National Institutes
of Health, 9609 Medical Center Drive,
Seventh Floor, West Tower, Room 7W514,
Bethesda, MD 20892, (240) 276–6458,
lopacw@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: FNLAC:
https://deainfo.nci.nih.gov/advisory/fac/
fac.htm, where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
PO 00000
Frm 00135
Fmt 4703
Sfmt 4703
Notice is hereby given of a change in
the meeting of the National Institute on
Aging Special Emphasis Panel, March
23, 2022, 11:30 a.m. to March 23, 2022,
02:30 p.m., National Institute on Aging,
Gateway Building, 7201 Wisconsin
Avenue, Bethesda, MD 20892, which
was published in the Federal Register
on December 28, 2021, FR Doc. 2021–
28091, 86 FR 73792.
The meeting notice is amended to
change the Contact Person from: Anita
H. Undale, MD, Ph.D., Scientific Review
Officer, Scientific Review Branch,
National Institute on Aging, National
Institutes of Health, Gateway Building,
Suite 2W200, 7201 Wisconsin Avenue,
Bethesda, MD 20892, 301–827–7428,
anita.undale@nih.gov to Bita Nakhai,
Ph.D., Scientific Review Officer,
Scientific Review Branch, National
Institute on Aging, National Institutes of
Health, Gateway Bldg., 2C212, 7201
Wisconsin Avenue, Bethesda, MD
20892, 301–402–7701, nakhaib@
nia.nih.gov. The meeting is closed to the
public. The meeting is closed to the
public.
Dated: January 31, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–02334 Filed 2–3–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
E:\FR\FM\04FEN1.SGM
04FEN1
6618
Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Initial Review Group; Mental
Health Services Study Section.
Date: March 3–4, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Aileen Schulte, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Room 6136, MSC 9606, Bethesda, MD 20852,
301–443–1225, aschulte@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: February 1, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–02373 Filed 2–3–22; 8:45 am]
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Philippe Marmillot, Ph.D.,
Scientific Review Officer, Extramural Project
Review Branch, 6700 B Rockledge Drive,
Room 2118, National Institute on Alcohol
Abuse and Alcoholism, Bethesda, MD 20892,
(301) 443–2861, marmillotp@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: February 1, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–02362 Filed 2–3–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Meeting for the
Interdepartmental Substance Use
Disorders Coordinating Committee
(ISUDCC)
National Institutes of Health
AGENCY:
Substance Abuse and Mental
Health Services Administration,
Department of Health and Human
Services.
ACTION: Notice.
lotter on DSK11XQN23PROD with NOTICES1
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; Collaborative Initiative on
Fetal Alcohol Spectrum Disorders (CIFASD)
Consortium Review Panel (RFA AA 21–
010,011,012,013,14).
Date: March 31, 2022.
VerDate Sep<11>2014
18:50 Feb 03, 2022
Jkt 256001
The Secretary of Health and
Human Services (Secretary) announces
a meeting of the Interdepartmental
Substance Use Disorders Coordinating
Committee (ISUDCC).
The ISUDCC is open to the public and
members of the public can attend the
meeting via telephone or webcast only,
and not in person. Agenda with call-in
information will be posted on the
SAMHSA website prior to the meeting
at: https://www.samhsa.gov/about-us/
advisory-councils/meetings. The
meeting will include information on
establishing ISUDCC working groups
support for the mission and work of the
Committee; federal advances to address
challenges in substance use disorder
(SUD); and non-federal advances to
address challenges in SUD.
Committee Name: Interdepartmental
Substance Use Disorders Coordinating
Committee (ISUDCC).
SUMMARY:
PO 00000
Frm 00136
Fmt 4703
Sfmt 4703
Date/Time/Type: March 16, 2022,
1:00 p.m.–4:00 p.m. (EDT)/Open.
ADDRESSES: The meeting will be held
virtually.
The meeting can be accessed via
Zoom.
SUPPLEMENTARY INFORMATION:
I. Background and Authority
The Interdepartmental Substance Use
Disorders Coordinating Committee is
required under Section 7022 of the
Substance Use-Disorder Prevention that
Promotes Opioid Recovery and
Treatment for Patients and Communities
Act (SUPPORT Act, Pub. L. 115–271) to
accomplish the following duties: (1)
Identify areas for improved coordination
of activities, if any, related to substance
use disorders, including research,
services, supports, and prevention
activities across all relevant federal
agencies; (2) identify and provide to the
Secretary recommendations for
improving federal programs for the
prevention and treatment of, and
recovery from, substance use disorders,
including by expanding access to
prevention, treatment, and recovery
services; (3) analyze substance use
disorder prevention and treatment
strategies in different regions of and
populations in the United States and
evaluate the extent to which federal
substance use disorder prevention and
treatment strategies are aligned with
State and local substance use disorder
prevention and treatment strategies; (4)
make recommendations to the Secretary
regarding any appropriate changes with
respect to the activities and strategies
described in items (1) through (3) above;
(5) make recommendations to the
Secretary regarding public participation
in decisions relating to substance use
disorders and the process by which
public feedback can be better integrated
into such decisions; and (6) make
recommendations to ensure that
substance use disorder research,
services, supports, and prevention
activities of the Department of Health
and Human Services and other federal
agencies are not unnecessarily
duplicative.
Not later than one year after the date
of the enactment of this Act, and
annually thereafter for the life of the
Committee, the Committee shall publish
on the internet website of the
Department of Health and Human
Services, which may include the public
information dashboard established
under section 1711 of the Public Health
Service Act, as added by section 7021,
a report summarizing the activities
carried out by the Committee pursuant
E:\FR\FM\04FEN1.SGM
04FEN1
]]>Agencies
[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Pages 6617-6618]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02373]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C.,
[[Page 6618]]
as amended. The grant applications and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Initial
Review Group; Mental Health Services Study Section.
Date: March 3-4, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Aileen Schulte, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, National Institutes of Health, Neuroscience Center,
6001 Executive Blvd., Room 6136, MSC 9606, Bethesda, MD 20852, 301-
443-1225, [email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental
Health Research Grants, National Institutes of Health, HHS)
Dated: February 1, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02373 Filed 2-3-22; 8:45 am]
BILLING CODE 4140-01-P
